Science & Enterprise subscription

Follow us on Twitter

  • A company developing a system with artificial intelligence to analyze medical literature for treatment insights is… https://t.co/TdK2vtumZo
    about 11 hours ago
  • New post on Science and Enterprise: Medical Knowledge A.I. Company Raises Early $4.8M https://t.co/lqYHuWQs7g #Science #Business
    about 11 hours ago
  • New contributed post on Science and Enterprise: https://t.co/3Gofb2uiDv Guidelines for Training New Employees
    about 14 hours ago
  • Regenstrief Institute, affiliated with Indiana University, is investing in a new company aiming to improve long-ter… https://t.co/87KTKEoWp8
    about 15 hours ago
  • New post on Science and Enterprise: Institute Invests in Elderly Care Start-Up https://t.co/mCNnAqV9yY #Science #Business
    about 15 hours ago

Please share Science & Enterprise

First Blood Disorder Crispr Treatments Reported

Sickle cell illustration

Early results from a clinical trial testing gene editing treatments for inherited blood disorders show the treatments helped patients improve their conditions. . . . → Read More: First Blood Disorder Crispr Treatments Reported

Stem Cells Grow New Spinal Disc Tissue

Tests with lab animals show stem cells derived from human donors can generate new spinal disc cells and tissue to help treat degenerating discs. . . . → Read More: Stem Cells Grow New Spinal Disc Tissue

Chip Device Simulates Islet Cell Functions

Islet cell chip

A new device testing the functions of insulin-producing islet cells in the pancreas is designed on a plastic chip made with common materials and manufacturing methods. . . . → Read More: Chip Device Simulates Islet Cell Functions

Industry-Academic Team Studies Myelin Renewal

Nerve cells illustration

Researchers are studying techniques for blocking proteins that damage myelin, the protective coating on nerve cells, as occurs in multiple sclerosis and other diseases. . . . → Read More: Industry-Academic Team Studies Myelin Renewal

Genentech, Biotech Partner on Multiple Sclerosis

Neurons illustration

A company designing treatments to restore the protective coating on nerve cells damaged by multiple sclerosis is collaborating with biotechnology enterprise Genentech. . . . → Read More: Genentech, Biotech Partner on Multiple Sclerosis

Stem Cell Start-Up Raises $250M in Venture Funds

T-cell lymphocyte

A company begun last year to create cancer therapies from banked, off-the-shelf stem cells is raising $250 million in its first round of venture financing. . . . → Read More: Stem Cell Start-Up Raises $250M in Venture Funds

Chip Device Simulates Blood-Brain Barrier

Brain circuits

A bioengineering lab developed a miniaturized chip with living cells that offers a realistic simulation of the blood-brain barrier to test new drugs. . . . → Read More: Chip Device Simulates Blood-Brain Barrier

Gold Nanoparticles Boost Crispr Delivery

Reza Shabazi and Jennifer Adair

Cancer researchers designed a technique using gold nanoscale particles for safer delivery of edited gene therapies to blood-forming stem cells. . . . → Read More: Gold Nanoparticles Boost Crispr Delivery

High-Speed 3-D Organ Printing in Development

Green laser beams

A research team in Europe and Israel is devising a new process for faster bio-printing of human organs with three-dimensional printing. . . . → Read More: High-Speed 3-D Organ Printing in Development

Viral Disease Biotech Joins ElevateBio, Gains $120M

T-cells illustration

A biotechnology company developing immunotherapies for viral diseases is joining the ElevateBio consortium providing manufacturing for cell and gene therapies. . . . → Read More: Viral Disease Biotech Joins ElevateBio, Gains $120M